Big Pharma is relying more on OTC, less on Rx drugs

06/17/2010 | Reuters

As patents expire and governments cut R&D spending, big drugmakers are slashing research payrolls, shifting their focus to consumer products and buying rights to drugs developed by smaller firms. Contract research organizations are stepping into the void and investing more in drug discovery.

View Full Article in: